A panel of 55 genes may predict poorer survival in breast ductal carcinoma in situ

Webb Elizabeth

首页> 外文期刊>Pharmacogenomics >A panel of 55 genes may predict poorer survival in breast ductal carcinoma in situ

【24h】

A panel of 55 genes may predict poorer survival in breast ductal carcinoma in situ

机译：一组55个基因可能预测乳腺癌在原位导管中的存活率较低

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Pharmacogenomics》 |2014年第5期|共1页
作者
Webb Elizabeth;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词

相似文献

外文文献
中文文献
专利

1. A panel of 55 genes may predict poorer survival in breast ductal carcinoma in situ [J] . Webb Elizabeth Pharmacogenomics . 2014,第5期

机译：一组55个基因可能预测乳腺癌在原位导管中的存活率较低
2. Higher expression levels of 14-3-3σ in ductal carcinoma in situ of the breast predict poorer outcome [J] . Nam K. Yoon, David B. Seligson, David Chia, Cancer Biomarkers . 2009,第4a5期

机译：乳腺导管癌中14-3-3σ的高表达水平预示较差的预后
3. Different panels of markers should be used to predict mammary Paget's disease associated with in situ or invasive ductal carcinoma of the breast. [J] . Lester T, Wang J, Bourne P, Annals of Clinical and Laboratory Science: Official Journal of the Association of Clinical Scientists . 2009,第1期

机译：应使用不同的标记物组来预测与乳腺原位或浸润性导管癌相关的乳腺Paget病。
4. Serum Biomarker Concentrations in Benign Breast Conditions and Ductal Carcinoma In Situ: Designing a Diagnostic Biomarker Panel That Can Distinguish Between Benign Conditions and Invasive Breast Cancer [C] . David E. Reese, Meredith C. Henderson, Susan Yeh, Molecular Medicine TRI-CON. . 2014

机译：血清生物标志物浓度在良性乳腺条件和导管癌原位：设计诊断生物标志物面板，可以区分良性条件和侵袭性乳腺癌
5. 14-3-3 zeta mediated epithelial -mesenchymal transition (EMT) contributes to ErbB2 overexpressing ductal carcinoma in situ (DCIS) progression into invasive breast cancer [D] . Lu, Jing 2008

机译：14-3-3 Zeta介导的上皮-间质转化（EMT）有助于ErbB2过表达导管原位癌（DCIS）演变为浸润性乳腺癌
6. Prolyl-4-hydroxylase Α subunit 2 (P4HA2) expression is a predictor of poor outcome in breast ductal carcinoma in situ (DCIS) [O] . Michael S. Toss, Islam M. Miligy, Kylie L. Gorringe, 2018

机译：脯氨酰-4-羟化酶A亚基2（P4HA2）表达是乳腺癌原位导管癌（DCIS）预后不良的预测指标
7. Predicting the Impact of Treatment Options on Survival and Breast Conservation in Patients With Ductal Carcinoma In Situ(DCIS) [O] . Rinaa Punglia, Natasha Stout, Angel Cronin, 2020

机译：预测人气癌患者患者存活和乳房保护的影响（DCIS）

A panel of 55 genes may predict poorer survival in breast ductal carcinoma in situ

著录项

相似文献

相关主题

期刊订阅